September 20, 2014 10:37 PM ET

Pharmaceuticals

Company Overview of Obagi Medical Products, Inc.

Company Overview

Obagi Medical Products, Inc., a specialty pharmaceutical company, develops, markets, and sells topical aesthetic and therapeutic prescription skin care systems. It offers Obagi Nu-Derm System, which include prescription and OTC drugs that are used for the treatment of fine lines, wrinkles, acne, photo damage, hyperpigmentation, melasma, laxity, and skin sallowness; Obagi Condition and Enhance Systems used before and after surgical and non-surgical cosmetic procedures; Obagi-C Rx System that comprises Vitamin C with 4% hydroquinone system; and Professional-C products consisting of Vitamin C serums. The company also provides ELASTIderm Eye and Décolletage, which increases the elasticity and sk...

3760 Kilroy Airport Way

Suite 500

Long Beach, CA 90806

United States

Founded in 1988

203 Employees

Phone:

562-628-1007

Fax:

562-628-1008

Key Executives for Obagi Medical Products, Inc.

Chief Executive Officer
Age: 54
Vice President of Manufacturing & Technical Services
Treasurer and Director
Age: 52
Secretary and Director
Age: 43
Vice President of International Sales & Marketing
Compensation as of Fiscal Year 2014.

Obagi Medical Products, Inc. Key Developments

Suneva Medical, Inc. Announces Plans to Expand Existing Partnership with Obagi Medical Products

Suneva Medical, Inc. announced plans to expand its existing partnership with Obagi Medical Products, Inc. (Obagi). Suneva Medical distributes, and is the exclusive licensee for, the full line of ReGenica(R) skincare products, and Obagi currently co-distributes ReGenica Facial Rejuvenation Complex. Under the terms of the existing agreement between the two companies, Obagi will now co-distribute ReGenica Advanced Rejuvenation Day Repair and ReGenica Advanced Rejuvenation Overnight Repair.

Obagi Medical Products, Inc. Announces Executive Changes

On April 25, 2013, Odysseus Acquisition Corp. merged with and into Obagi Medical Products, Inc., with Obagi surviving the merger and continuing as a wholly-owned subsidiary of Valeant Pharmaceuticals International. In connection with the Merger, at the Effective Time, Albert F. Hummel, Albert J. Fitzgibbons, Ronald P. Badie, John A. Bartholdson, John H. Duerden, Howard A. Grant and Kristina M. Leslie resigned as directors of Obagi. Pursuant to the terms of the Merger Agreement, at the Effective Time the directors and officers of Purchaser immediately prior to the Effective Time became the directors and officers of Obagi following the Merger. Accordingly, as of April 25, 2013, Mr. Hummel, the Chief Executive Officer, Preston S. Romm, the Chief Financial Officer, David S. Goldstein, the Executive Vice President, Laura B. Hunter, the Vice President, General Counsel and Secretary, and Mark T. Taylor, the Senior Vice President, ceased being executive officers of Obagi and J. Michael Pearson assumed the role of director, President and Chief Executive Officer of Obagi, Howard B. Schiller assumed the role of director and Treasurer of Obagi and Robert R. Chai-Onn assumed the role of director and Secretary of Obagi. At the time Messrs. Schiller, Chai-Onn and Pearson assumed the role of director, it had not yet been determined which committees, if any, of the Board of Directors of Obagi on which Messrs. Schiller, Chai-Onn and Pearson would serve.

Obagi Medical Products, Inc.(NasdaqGS:OMPI) dropped from NASDAQ Composite Index

Obagi Medical Products, Inc. will be removed from NASDAQ Composite Index.

Similar Private Companies By Industry

Company Name Region
Planet Biotechnology Inc. United States
Sarken, Inc. United States
Inspiration Biopharmaceuticals, Inc. United States
Whole In One Organics, Ltd. United States
NanoBio Corporation United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Obagi Medical Products, Inc., please visit www.obagi.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.